Literature DB >> 12892988

Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.

Ellen W Freeman1.   

Abstract

Because of the prevalence, chronicity and distress caused by premenstrual symptoms (PMS), diagnosis and effective treatments are important information for clinicians. The DSM-IV requires at least five specified symptoms for premenstrual dysphoric disorder (PMDD), a severe dysphoric form of PMS, while the ICD-10 requires only one distressing symptom for a diagnosis of PMS. Many women who seek treatment fall between these two diagnostic approaches, and standard diagnostic criteria for clinically significant PMS are needed. A diagnosis of PMS consists of determining the timing of the symptoms in relation to menses, meaningful change between post- and premenstrual symptom severity and a clinically significant severity of the symptoms. A differential diagnosis to distinguish PMS from other medical and psychiatric conditions is important for appropriate treatment. No hormone or laboratory test indicates a PMS diagnosis. The current diagnostic standard requires confirmation of subjective symptom reports by prospective daily diaries. Diagnostic criteria for PMS must recognize the broad range of symptoms, the temporal pattern of the symptoms and the critical issue of symptom severity, which differentiates clinically significant PMS from normal menstrual cycle changes.

Entities:  

Mesh:

Year:  2003        PMID: 12892988     DOI: 10.1016/s0306-4530(03)00099-4

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  45 in total

1.  Psychotic episodes during menstruation in a 12-year-old girl: a case of menstrual psychosis.

Authors:  Barbara Dorothea Grünewald; Alexander Korte; Gerd Schulte-Körne
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-01-24       Impact factor: 4.785

Review 2.  Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis.

Authors:  Maria Kleinstäuber; Michael Witthöft; Wolfgang Hiller
Journal:  J Clin Psychol Med Settings       Date:  2012-09

3.  Reduced parasympathetic activity during sleep in the symptomatic phase of severe premenstrual syndrome.

Authors:  Fiona C Baker; Ian M Colrain; John Trinder
Journal:  J Psychosom Res       Date:  2008-06-04       Impact factor: 3.006

Review 4.  Vitamin D and the occurrence of depression: causal association or circumstantial evidence?

Authors:  Elizabeth R Bertone-Johnson
Journal:  Nutr Rev       Date:  2009-08       Impact factor: 7.110

5.  Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigue.

Authors:  Doerte U Junghaenel; Stefan Schneider; Arthur A Stone; Christopher Christodoulou; Joan E Broderick
Journal:  J Psychosom Res       Date:  2014-02-07       Impact factor: 3.006

Review 6.  Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?

Authors:  Uriel Halbreich; P M Shaughn O'Brien; Elias Eriksson; Torbjörn Bäckström; Kimberly A Yonkers; Ellen W Freeman
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Perceived stress and severity of perimenstrual symptoms: the BioCycle Study.

Authors:  Audra L Gollenberg; Mary L Hediger; Sunni L Mumford; Brian W Whitcomb; Kathleen M Hovey; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Womens Health (Larchmt)       Date:  2010-05       Impact factor: 2.681

8.  Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women.

Authors:  Nayoung Kim; Ha-Na Yoo; Hye Sun Hyun; Dong-Yun Lee; Byung-Koo Yoon; Doo-Seok Choi
Journal:  Obstet Gynecol Sci       Date:  2015-09-22

9.  Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.

Authors:  Y Inoue; T Terao; N Iwata; K Okamoto; H Kojima; T Okamoto; R Yoshimura; J Nakamura
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

10.  The role of emotion regulation in the experience of menstrual symptoms and perceived control over anxiety-related events across the menstrual cycle.

Authors:  Sanjana Manikandan; Yael I Nillni; Michael J Zvolensky; Kelly J Rohan; Krystle R Carkeek; Teresa M Leyro
Journal:  Arch Womens Ment Health       Date:  2016-08-25       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.